Live from the NIH registry
Studies recruiting near Frederick right now
Top 25 of 255 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (29.4 mi)
· Sponsor: NRG Oncology
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Opioid-use Disorder
Phase 2, Phase 3
Interventional 180 participants sought
Avery Road Treatment Center (ARTC) — Rockville, Maryland (27.9 mi)
· Sponsor: New York State Psychiatric Institute
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Maryland Oncology Hematology P.A. — Germantown, Maryland (19.5 mi)
· Sponsor: Pfizer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (1.4 mi)
· Sponsor: Eli Lilly and Company
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
William E Kahlert Regional Cancer Center/Sinai Hospital — Westminster, Maryland (24.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Adams Cancer Center — Gettysburg, Pennsylvania (29.1 mi)
· Sponsor: NRG Oncology
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Schizophrenia
Phase 2
Interventional 268 participants sought
Cbh Health - Gaithersburg /ID# 272932 — Gaithersburg, Maryland (23.1 mi)
· Sponsor: AbbVie
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Major Depressive Disorder (MDD)
Phase 2
Interventional 300 participants sought
Draig Clinical Site — Gaithersburg, Maryland (23.1 mi)
· Sponsor: Draig Therapeutics Ltd
Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes
Prediabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
N/A
Interventional 120 participants sought
Johns Hopkins Community Physicians Frederick — Frederick, Maryland (1.4 mi)
· Sponsor: Johns Hopkins University
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Adams Cancer Center — Gettysburg, Pennsylvania (29.1 mi)
· Sponsor: SWOG Cancer Research Network
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Local Institution - 0067 — Hagerstown, Maryland (21.7 mi)
· Sponsor: Bristol-Myers Squibb
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Mid Atlantic Retina Specialists - Hagerstown /ID# 274725 — Hagerstown, Maryland (21.7 mi)
· Sponsor: AbbVie
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Ability x Ottobock.care — Frederick, Maryland (1.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (1.4 mi)
· Sponsor: Gilead Sciences
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
CBH Health — Gaithersburg, Maryland (23.1 mi)
· Sponsor: Bristol-Myers Squibb
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
U.S. Dermatology Partners - Rockville — Rockville, Maryland (27.9 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0146 - Maryland Oncology Hematology, PA — Rockville, Maryland (27.9 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Adams Cancer Center — Gettysburg, Pennsylvania (29.1 mi)
· Sponsor: NRG Oncology
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Klein & Associates, M.D., P.A. — Hagerstown, Maryland (21.7 mi)
· Sponsor: Takeda
SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques
Infertility, Female, Reproductive Techniques, Assisted
N/A
Interventional 95 participants sought
Shady Grove Fertility Rockville — Rockville, Maryland (27.9 mi)
· Sponsor: Shady Grove Fertility Reproductive Science Center
Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos
Complex Aneuploidy, Chaotic Aneuploidy
N/A
Observational 280 participants sought
Shady Grove Fertility — Rockville, Maryland (27.9 mi)
· Sponsor: Shady Grove Fertility Reproductive Science Center
Cancer in Inherited Bone Marrow Failure Syndromes
Diamond Blackfan Anemia, Dyskeratosis Congenita
N/A
Observational 4,000 participants sought
National Cancer Institute - Shady Grove — Rockville, Maryland (27.9 mi)
· Sponsor: National Cancer Institute (NCI)
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
William E Kahlert Regional Cancer Center/Sinai Hospital — Westminster, Maryland (24.4 mi)
· Sponsor: SWOG Cancer Research Network
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Kaiser Permanente-Gaithersburg Medical Center — Gaithersburg, Maryland (23.1 mi)
· Sponsor: NRG Oncology
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (21.7 mi)
· Sponsor: ONL Therapeutics